Page last updated: 2024-10-21

4-aminobenzamidine and Hypertension

4-aminobenzamidine has been researched along with Hypertension in 1 studies

4-aminobenzamidine: a urokinase inhibitor; inhibits acrosin; structure given in first source

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dutra, JBR1
Lacerda, IS1
Nunes, ADC1
Bessa, ASM1
Jesus, ÉF1
Pontes, CNR1
Naves, LM1
Pedrino, GR1
Mendes, EP1
Fraga-Silva, RA1
Costa-Fraga, FP1
Stergiopulos, N1
Kangussu, LM1
Faraco, AAG1
Ferreira, AJ1
Castro, CH1

Other Studies

1 other study available for 4-aminobenzamidine and Hypertension

ArticleYear
p-Aminobenzamidine attenuates cardiovascular dysfunctions in spontaneously hypertensive rats.
    Life sciences, 2022, Sep-01, Volume: 304

    Topics: Angiotensin-Converting Enzyme 2; Animals; Benzamidines; Blood Pressure; Hypertension; Rats; Rats, In

2022